News
Fideres Advises in Billion-Pound UK Class Action Against Microsoft Azure
Today Dr Maria Luisa Stasi filed UK legal proceedings against Microsoft on the basis of its conduct in the cloud computing services. Fideres has wo...
The Philadelphia Inquirer recently covered Fideres’s recent research on price increases of generic drugs as part of a full examination of the pharmaceutical industry.
Alberto Thomas, founding partner at Fideres, is quoted as describing the price increases as occurring “without any meaningful increases in the costs of materials or production costs or breakdown of factories or other disruption to the supply chain. That’s what makes this very suspicious.”
The full article by the Philadelphia Inquirer can be found here.
Today Dr Maria Luisa Stasi filed UK legal proceedings against Microsoft on the basis of its conduct in the cloud computing services. Fideres has wo...
We at Fideres are happy to see the European Commission publish “Exploring Aspect of the State of Competition in the EU”. This overa...
Today, Fideres’s research has been cited in a Business Insider article on Blackstone’s BREIT Valuation Issue, view Fideres’s orig...